Ventolin and Tongue disorder - a phase IV clinical study of FDA data

Summary:

Tongue disorder is reported as a side effect among people who take Ventolin (albuterol), especially for people who are female, 50-59 old, also take Symbicort, and have High blood pressure.

The phase IV clinical study analyzes which people have Tongue disorder when taking Ventolin. It is created by eHealthMe based on reports of 50,731 people who have side effects when taking Ventolin from the FDA, and is updated regularly.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

What is Tongue disorder?

Tongue disorder (disease of tongue) is found to be associated with 763 drugs and 964 conditions by eHealthMe. Check the latest studies of Tongue disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

50,731 people reported to have side effects when taking Ventolin.
Among them, 44 people (0.09%) have Tongue disorder.

Among these 44 people:

What is the gender of people who have Tongue disorder when taking Ventolin? *

female: 70.45 %
male: 29.55 %

What is the age of people who have Tongue disorder when taking Ventolin? *

What are other drugs people take besides Ventolin? *

What are other side effects people have besides Tongue disorder? *

Hypersensitivity: 18 people, 40.91%
Throat Irritation: 17 people, 38.64%
Headache (pain in head): 14 people, 31.82%
Nausea (feeling of having an urge to vomit): 13 people, 29.55%
Muscle Aches (muscle pain): 13 people, 29.55%
Dizziness: 12 people, 27.27%
Dyspnea (difficult or laboured breathing): 12 people, 27.27%
Cough: 12 people, 27.27%
Nasopharyngitis (inflammation of the nasopharynx): 11 people, 25.00%
Paraesthesia Oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect): 9 people, 20.45%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 13.64%
Nasal Polyps (masses that develop in the lining of the nose): 5 people, 11.36%
Hypersensitivity: 4 people, 9.09%
Prostate Cancer Metastatic: 1 person, 2.27%
Neuralgia (pain in one or more nerves): 1 person, 2.27%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 2.27%
Dyspnea (difficult or laboured breathing): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin and have Tongue disorder?

- Check whether Tongue disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ventolin:

Ventolin (51,849 reports)

Tongue disorder treatments and more:

Tongue disorder (8,897 reports)

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tongue disorder:

Tongue disorder (763 drugs)

Browse all the conditions that are associated with Tongue disorder:

Tongue disorder (964 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol (the active ingredients of Ventolin) and Ventolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.